Shepherd Kaplan Krochuk’s abrdn Life Sciences Investors HQL Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,290	Closed	-$262K	–	198
2021 Q1	$262K	Sell	13,290 -5,230	-28%	-$108K	0.1%	140
2020 Q4	$366K	Hold	18,520	–	–	0.14%	115
2020 Q3	$326K	Hold	18,520	–	–	0.14%	114
2020 Q2	$333K	Hold	18,520	–	–	0.15%	115
2020 Q1	$277K	Buy	18,520 +1,850	+11%	+$30.3K	0.45%	75
2019 Q4	$291K	Buy	16,670 +4,150	+33%	+$68.1K	0.22%	119
2019 Q3	$189K	Buy	+12,520	New	+$201K	0.14%	139

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Shepherd Kaplan Krochuk's HQL Position: Q2 2021 in Review

Shepherd Kaplan Krochuk sold out of abrdn Life Sciences Investors (HQL) in Q2 2021, closing a stake of 13,290 shares — an estimated $262K sold.

Shepherd Kaplan Krochuk first reported a position in HQL in Q3 2019 and held it in 7 quarters. The position peaked at $366K in Q4 2020. 67 funds tracked by Wall St. Rank hold HQL as of Q2 2021.

Shepherd Kaplan Krochuk reported no remaining abrdn Life Sciences Investors position as of Q2 2021 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 13,290 abrdn Life Sciences Investors shares in Q2 2021, an estimated $262K.
Shepherd Kaplan Krochuk first reported a position in abrdn Life Sciences Investors in Q3 2019 and held it in 7 quarters.
Shepherd Kaplan Krochuk's abrdn Life Sciences Investors position peaked at $366K in Q4 2020.
67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2021.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2021, filed 10 Aug 2021.